May state legislative applications limit an Article V convention? Subject, yes; specific language, probably not
- September 12, 2013
Government CER (Comparative Effectiveness Research) sounds like a progressive solution, but it is actually a frightening move that puts government detailers between patients and doctors and favors one-size-fits-none cost cutting over continued medical progres Continue reading
READ MOREThis paper illustrates how one jurisdiction could take the lead in defining medical freedom in the United States and create a safe haven for innovation, alternative care, and affordable treatment. Continue reading
READ MORE“Over the past two years shortages have developed for over 180 drugs, including cancer treatments. [Why?] FDA regulation, government price controls on already discounted but complex drugs, and policies that discourage the use of new medications.” Continue reading
READ MORESo-called “Accountable Care Organization” pits doctors’ financial incentives against what is best for patients.
READ MOREThe federal government has created a cancer drug shortage. How? Because of what are essentially government prices controls on generic cancer drugs.
READ MORE[I]nnovations get better over time. But if you impede the first generation the second generation may never come into existence and, as Mandel notes, no first-generation device could satisfy the FDA’s conditions. It’s like refusing to give the Wright Brothers a license to fly because their first airplane only flew for 59 seconds.
READ MORE